InvestorsHub Logo
Followers 12
Posts 1448
Boards Moderated 0
Alias Born 03/12/2020

Re: None

Wednesday, 07/13/2022 11:32:31 PM

Wednesday, July 13, 2022 11:32:31 PM

Post# of 44516
Great article for those who have not read this. Dr. Chew, who is the lead investigator on the CUBT animal trials currently in week 11, is the doctor quoted here in talking about AMD patients moving away from monthly injections. The treatment discussed here, while effective, has complications surrounding it.

Now I understand why Dr. Chew had an interest in being the lead investigator on the CUBT Metformin trials. The article gave me goose bumps quite frankly. This is a hidden gem people. And Dr Bharti, also from the NEI, is the inventor of the Metformin eye drop solution and on the CUBT board of advisors. Connect the dots. And right now this company is only a $18M market cap. Ridiculously low.

https://consumer.healthday.com/1-24-some-patients-with-macular-degeneration-could-stop-monthly-eye-injections-2656425654.html